We report structure-guided modifications of the benzyloxy substituent of the
Insulin-like Growth Factor-1 Receptor (IGF-1R) inhibitor NVP-AEW541. This
chemical group has been shown to confer selectivity against other protein
kinases but at the expense of a metabolism liability. X-ray crystallography has
revealed that the benzyloxy moiety interacts with a lysine cation of the IGF-1R
kinase domain via its ether function and its aromatic π-system and is nicely
embedded in an induced hydrophobic pocket. We show that 1,4-diethers displaying
an adequate hydrophobic and constrained shape are advantageous benzyloxy
replacements. A single digit nanomolar inhibitor (compound 20, IC50=8.9nM) was
identified following this approach.